Alder BioPharmaceuticals' IPO

Alder BioPharmaceuticals raised a round of funding on May 08, 2014. Investors include Public.

Alder BioPharmaceuticals identifies, develops and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas. The com…

Articles about Alder BioPharmaceuticals' IPO: